ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1118

The Performance of Behcet’s Disease Clinical Diagnostic Criteria in a Low Prevalence Region. A Retrospective Single Center Cohort Study

Muhammad Shamim1, Mazen Allouni2, Haseeb Chaudhary3 and Omer Pamuk4, 1University Hospitals/ Case Western Reserve University, Cuyahoga Falls, OH, 2Case Western Reserve, University Hospitals, Cleveland Medical Center, Cleveland, OH, 3Case Western Reserve University, Westlake, OH, 4University Hospitals Cleveland Medical Center/ Case Western Reserve University, Cleveland, OH

Meeting: ACR Convergence 2024

Keywords: Behçet's Syndrome, classification criteria, Cohort Study, Diagnostic criteria, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The diagnosis of Behcet’s Disease (BD) is particularly challenging in non-endemic areas because of milder disease presentations and lack of specific tests. Prior studies have shown that utilization of the available classification criteria often led to overdiagnosis in non-endemic areas. Our goal was to evaluate the performance of the three BD classification criteria in North America, a low-prevalence area.

Methods: A retrospective chart review was performed between 2014-2024. We searched our local EMR system by using the terms “Behcet”, Behcet’s syndrome” and “Behcet’s disease”. In addition, we used ICD-10 code for BS (ICD-M35.2). Clinical data were obtained from electronic health records. ISG 1990, ICBD 2014 and Japanese Society criteria were applied to our patients with a clinical diagnosis of BD.

Results: The initial search yielded 205 patients. In 146 patients, alternate diagnosis was deemed more plausible and were excluded. The major manifestations of these groups were oral ulcer (94%), genital ulcers (57%) and ocular disease (26%). We further analyzed 59 patients with a clinical diagnosis of BS as summarized in Table 1. Most were female (83%) and the mean age was 45.1±17.40.  Majority of the patients were White (68%).

Table 2 shows the sensitivity of available classification criteria against clinically diagnosed BD. 53% patients fulfilled ISG 1990 and 81% fulfilled ICBD criteria. Both criteria had higher sensitivity for male patients with BD. The sensitivity of Japanese criteria was very low, especially in females (only 2%). Incomplete Japanese criteria showed 85% sensitivity. The most common treatment modalities were colchicine 29 (49%), steroids 22 (37%) and azathioprine 19 (32%). 18 (31%) patients used TNFi and 11 (19%) patients used Apremilast. During the follow-up, the initial diagnosis of BD was revised to lupus in 3, and inflammatory bowel disease in 2 patients. Malignancy and relapsing polychondritis developed in one patient. Coronary artery aneurysm and CNS disease was detected in one patient. Our chart review did not reveal any severe visual loss or mortality.

Conclusion: Our cohort showed higher female predominance, low major organ involvement, low prevalence of HLA- B51, and low mortality. The sensitivity of ISG was lower than ICBD criteria for diagnosis of BD, especially in female patients. The complete Japanese criteria had a poor sensitivity in both males and females.

Supporting image 1

Supporting image 2


Disclosures: M. Shamim: None; M. Allouni: None; H. Chaudhary: None; O. Pamuk: None.

To cite this abstract in AMA style:

Shamim M, Allouni M, Chaudhary H, Pamuk O. The Performance of Behcet’s Disease Clinical Diagnostic Criteria in a Low Prevalence Region. A Retrospective Single Center Cohort Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-performance-of-behcets-disease-clinical-diagnostic-criteria-in-a-low-prevalence-region-a-retrospective-single-center-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-performance-of-behcets-disease-clinical-diagnostic-criteria-in-a-low-prevalence-region-a-retrospective-single-center-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology